Nothing Special   »   [go: up one dir, main page]

DE68925275D1 - Endotoxin-bindeprotein und dessen verwendung - Google Patents

Endotoxin-bindeprotein und dessen verwendung

Info

Publication number
DE68925275D1
DE68925275D1 DE68925275T DE68925275T DE68925275D1 DE 68925275 D1 DE68925275 D1 DE 68925275D1 DE 68925275 T DE68925275 T DE 68925275T DE 68925275 T DE68925275 T DE 68925275T DE 68925275 D1 DE68925275 D1 DE 68925275D1
Authority
DE
Germany
Prior art keywords
endotoxin
proteins
binding protein
endotoxin binding
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68925275T
Other languages
English (en)
Other versions
DE68925275T2 (de
Inventor
Norman Wainwright
Thomas Novitsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Associates of Cape Cod Inc
Original Assignee
Associates of Cape Cod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Associates of Cape Cod Inc filed Critical Associates of Cape Cod Inc
Publication of DE68925275D1 publication Critical patent/DE68925275D1/de
Application granted granted Critical
Publication of DE68925275T2 publication Critical patent/DE68925275T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438Electrodes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/579Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving limulus lysate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/12Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the preparation of the feed
    • B01D15/125Pre-filtration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
DE68925275T 1988-06-23 1989-06-21 Endotoxin-bindeprotein und dessen verwendung Expired - Fee Related DE68925275T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21057588A 1988-06-23 1988-06-23
PCT/US1989/002665 WO1989012644A1 (en) 1988-06-23 1989-06-21 Endotoxin binding protein and uses thereof

Publications (2)

Publication Number Publication Date
DE68925275D1 true DE68925275D1 (de) 1996-02-08
DE68925275T2 DE68925275T2 (de) 1996-08-22

Family

ID=22783435

Family Applications (2)

Application Number Title Priority Date Filing Date
DE68925275T Expired - Fee Related DE68925275T2 (de) 1988-06-23 1989-06-21 Endotoxin-bindeprotein und dessen verwendung
DE68929334T Expired - Fee Related DE68929334T2 (de) 1988-06-23 1989-06-21 Verfahren zumm Assay von Endotoxin-Konzentration

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE68929334T Expired - Fee Related DE68929334T2 (de) 1988-06-23 1989-06-21 Verfahren zumm Assay von Endotoxin-Konzentration

Country Status (7)

Country Link
EP (2) EP0379549B1 (de)
JP (1) JP2774343B2 (de)
AT (1) ATE207205T1 (de)
AU (1) AU3772289A (de)
CA (1) CA1338836C (de)
DE (2) DE68925275T2 (de)
WO (1) WO1989012644A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK255887D0 (da) * 1987-05-20 1987-05-20 Claus Koch Immunoassay
US5594113A (en) * 1988-06-23 1997-01-14 Associates Of Cape Cod, Inc. Endotoxin binding and neutralizing protein and uses thereof
JPH06508604A (ja) * 1991-02-22 1994-09-29 マサチューセッツ インスティテュート オブ テクノロジー 内毒素血症の治療
AU2007192A (en) * 1991-05-08 1992-12-21 Vertex Pharmaceuticals Incorporated Rfkbp: a novel prolyl isomerase and rapamycin/fk506 binding protein
DE69232307T2 (de) * 1991-05-16 2002-07-18 Associates Of Cape Cod, Inc. Endotoxinbindendes und -neutralisierendes protein und verwendungen dafür
US6274348B1 (en) 1992-05-19 2001-08-14 Xoma Corporation Methods for the preparation of positively charged proteins
AU669723B2 (en) * 1992-05-19 1996-06-20 Xoma Corporation Improved methods for the preparation of endotoxin-binding proteins
JP3402476B2 (ja) * 1992-08-24 2003-05-06 生化学工業株式会社 リポ多糖結合性タンパク質及びその製造法
WO1995005393A2 (en) * 1993-08-18 1995-02-23 Morphosys Gesellschaft Für Proteinoptimierung Mbh Lipopolysaccharide-binding and neutralizing peptides
ES2178656T3 (es) * 1993-09-22 2003-01-01 Xoma Technology Ltd Metodo para tratar infeccion bacteriana gram-negativa por administracion de productos de proteina bactericida que aumenta la permebilidad(bpi) y antibioticos.
US5624904A (en) * 1993-11-17 1997-04-29 Massachusetts Institute Of Technology Method for treating gram positive septicemia
US5578568A (en) * 1994-04-22 1996-11-26 Xoma Corporation Method of treating conditions associated with intestinal ischemia/reperfusion
US5932536A (en) * 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
FR2739448B1 (fr) * 1995-09-29 1997-10-24 Thomson Csf Dispositif de detection et de controle de biofilms
US5780429A (en) * 1995-12-22 1998-07-14 Marine Biological Laboratory Anti-LPS factor from horseshoe crabs and methods of use
CN1293383C (zh) * 2005-01-13 2007-01-03 丁友玲 一种临床检测试剂的制备方法
JP7327096B2 (ja) * 2019-11-13 2023-08-16 株式会社島津製作所 分子の分離方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107077A (en) 1975-07-14 1978-08-15 Associates Of Cape Cod, Inc. Limulus lysate of improved sensitivity and preparing the same
US4201865A (en) 1976-01-15 1980-05-06 Gruppo Lepetit S.P.A. Novel prostaglandin analogues
US4038147A (en) 1976-06-15 1977-07-26 Becton, Dickinson And Company Method for detecting endotoxins
US4221866A (en) 1978-10-06 1980-09-09 Baxter Travenol Laboratories, Inc. Method for determining endotoxin concentration
US4276050A (en) 1980-01-10 1981-06-30 Abbott Laboratories Method for systemic endotoxin detection
US4273557A (en) 1980-03-31 1981-06-16 Mallinckrodt, Inc. Limulus lysate procedure for determining endotoxins
FR2497798A1 (fr) * 1981-01-09 1982-07-16 Pharmindustrie Nouveaux peptides portant un fluorophore, procede pour leur preparation et leur application au dosage fluorimetrique des endotoxines
US4614714A (en) 1982-08-21 1986-09-30 Yamasa Shoyu Kabushiki Kaisha Use of novel L-glutamic acid oxidase
US4758655A (en) * 1983-01-03 1988-07-19 Scripps Clinic And Research Foundation Synthetic polypeptide corresponding to a portion of the heat-labile enterotoxin of escherichia coli, compositions and methods of therewith
US4713347A (en) * 1985-01-14 1987-12-15 Sensor Diagnostics, Inc. Measurement of ligand/anti-ligand interactions using bulk conductance
US4780529A (en) * 1985-08-09 1988-10-25 Biotech Research Laboratories, Inc. Isolation of an endotoxin inactivator from human plasma, and methods of use
US4677194A (en) 1985-08-09 1987-06-30 Biotech Research Laboratories, Inc. Isolation of an endotoxin inactivator from human plasma
USH201H (en) 1985-08-23 1987-01-06 United States Of America Biosensors from membrane proteins reconstituted in polymerized lipid bilayers
US4680268A (en) 1985-09-18 1987-07-14 Children's Hospital Medical Center Implantable gas-containing biosensor and method for measuring an analyte such as glucose
US4717658A (en) * 1985-12-03 1988-01-05 Miles Inc. Gram negative bacteria screening method with horseshoe crab amebocyte lysate (LAL)

Also Published As

Publication number Publication date
CA1338836C (en) 1997-01-07
DE68929334D1 (de) 2001-11-22
EP0379549A4 (en) 1992-04-01
DE68929334T2 (de) 2005-08-18
ATE207205T1 (de) 2001-11-15
EP0687911B1 (de) 2001-10-17
DE68925275T2 (de) 1996-08-22
JP2774343B2 (ja) 1998-07-09
WO1989012644A1 (en) 1989-12-28
JPH03501733A (ja) 1991-04-18
EP0687911A3 (de) 1996-08-21
EP0379549B1 (de) 1995-12-27
EP0687911A2 (de) 1995-12-20
AU3772289A (en) 1990-01-12
EP0379549A1 (de) 1990-08-01

Similar Documents

Publication Publication Date Title
DE68925275D1 (de) Endotoxin-bindeprotein und dessen verwendung
NO961115D0 (no) Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
ES2149149T1 (es) Proteinas de fijacion de interleuquina-18, su preparacion y utilizacion.
EP1067182A8 (de) Sekretorische- oder Membranproteine
DK228190D0 (da) Rajgraespollenallergen
NO885013D0 (no) FremgangsmŸte for fremstilling av bionedbrytbare mikrokapsler av vannopplelige peptider og proteiner, samt mikroka psler oppnŸdd ved fremgangsmŸten.
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
DE69634077D1 (de) Haemophilus adhäsionsproteinen
DE69728897D1 (de) Saeugetierchemokine
SE9602822D0 (sv) New receptor
DE68910771D1 (de) Verfahren zur Herstellung von verbessertem Proteinhydrolysat.
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
DK0972781T3 (da) Protein S-polypeptider og anvendelser deraf
CA2199403A1 (en) Novel PKA-Binding Proteins and Uses Thereof
DE69327167D1 (de) Nukleotidsequenzen die fur proteine von cryptosporidium kodieren, polypeptide, welche durch diese sequenzen kodiert werden, und kits fur deren benutzung
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DE59004279D1 (de) Verfahren zur C-terminalen Modifizierung von Proteinen.
PT524421E (pt) Herpesvirus humano tipo 6 proteina p 100, sequencias de adn correspondentes, preparacao e utilizacao
SE9604439D0 (sv) New receptor
AU1566292A (en) Protein allergens of the species cynodon dactylon
RU94026276A (ru) Рецепторы интерлейкина-12 и антител
ATE342972T1 (de) Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
AU6425196A (en) Protein allergens of the species Cynodon dactylon
IT8921396A0 (it) Procedimento per la sintesi di peptidi preventivamente identificati come siti di interazione di proteine interagenti.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: GROSSE, BOCKHORNI, SCHUMACHER, 45133 ESSEN

8339 Ceased/non-payment of the annual fee